CJC-1295 no DAC
Mod-GRF 1-29 · CJC-1295 without DAC
Le CJC-1295 sans DAC (Mod-GRF 1-29) est un analogue de synthèse de la GHRH étudié en recherche in vitro et préclinique comme outil d'étude de la voie GHRH. Réactif de recherche uniquement — non destiné à la consommation humaine.
CJC-1295 no DAC
Analogue de la GHRH étudié in vitro pour la voie de l'hormone de croissance.
Voir le CJC-1295 no DACEn bref
- Classe
- Analogue de la GHRH
- Cible
- Récepteur GHRH
- Forme
- Lyophilisée (poudre)
- Statut
- Research Use Only
Axes de recherche documentés
Bibliothèque d'études
Tous les résultats sur PubMedProlonged stimulation of growth hormone (GH) and insulin-like growth factor I secretion by CJC-1295, a long-acting analog of GH-releasing hormone, in healthy adults.
Teichman SL, et al. · The Journal of clinical endocrinology and metabolism · 2006
Therapeutic Peptides in Orthopaedics: Applications, Challenges, and Future Directions.
Rahman OF, et al. · Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2026
Injectable Peptide Therapy: A Primer for Orthopaedic and Sports Medicine Physicians.
Mayfield CK, et al. · The American journal of sports medicine · 2026
Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.
Mendias CL, et al. · Sports medicine (Auckland, N.Z.) · 2026
Peptide Supplements and Their Therapeutic Applications in Sports Medicine.
Tewari K, et al. · The American journal of sports medicine · 2026
Therapeutic Peptides in Aesthetic, Metabolic and Endocrine Conditions: Effects, Safety, Clinical Applications, and Future Perspectives.
Renke G, et al. · International journal of molecular sciences · 2026
Activation of the GH/IGF-1 axis by CJC-1295, a long-acting GHRH analog, results in serum protein profile changes in normal adult subjects.
Sackmann-Sala L, et al. · Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society · 2009
Therapeutic peptides in gerontology: mechanisms and applications for healthy aging.
Mavrych V, et al. · Frontiers in aging · 2026
Human growth hormone-releasing factor (hGRF)1-29-albumin bioconjugates activate the GRF receptor on the anterior pituitary in rats: identification of CJC-1295 as a long-lasting GRF analog.
Jetté L, et al. · Endocrinology · 2005
Advances in the detection of growth hormone releasing hormone synthetic analogs.
Memdouh S, et al. · Drug testing and analysis · 2021
A new era of doping? Use of peptide and peptide-analog drugs in recreational and professional sport and bodybuilding: a critical review.
Coutinho LFD, et al. · The Journal of sports medicine and physical fitness · 2026
Netnography of Female Use of the Synthetic Growth Hormone CJC-1295: Pulses and Potions.
Van Hout MC, et al. · Substance use & misuse · 2016
Résultats récupérés en direct depuis PubMed (NCBI). Littérature de recherche uniquement — aucun conseil médical.
Peptides de recherche — Research Use Only
- Non destinés à la consommation humaine
- Non destinés au diagnostic, au traitement ou à la prévention d'une maladie